Alex Jones (Phd/Ceo) Email & Phone Number

We provide the best multiparametric cell sorting solution for Cell and Gene Therapy (CGT) both manufacture and R&D, and for general research. If either sterility, easy of use, speed or biosaftey is important to you, check out our website. This is a call to Cell and Gene Therapy companies - if you need multiparametric cell sorting, Cellular Highways - Highway1 can be up to 4x faster to produce a dose (based on an output of 60 million sorted cells*) compared to other solutions. Offering potential production cost savings of over 80% per dose (based on an annual requirment of 10,000 doses**). Don't just take my word for it - ask for a demo and see for yourself why the Highway1 is fast becoming the preferred, scalable solution for many companies and researchers, from early discovery through to manufacture. *includes both sorting time (enabled by VACs - Vortex Actuated Cell Sorting) and process time ** calculated based on consumable costs, HR/operator cost and facilities costs(data collected over 2 years from numerous real world head-to-head comparisions and published specifications)Providing for:𝐏𝐮𝐫𝐢𝐭𝐲 & 𝐇𝐨𝐦𝐨𝐠𝐞𝐧𝐞𝐢𝐭𝐲: Cell therapies incrasingly require highly purified and homogeneous cell populations to ensure safety and efficacy. We enable the isolation of specific cell types from a heterogeneous mixture, allowing for the removal of unwanted cells and the enrichment of the desired population. This purity is essential to minimize the risk of adverse reactions and ensure consistent therapeutic outcomes.𝐒𝐜𝐚𝐥𝐞-𝐮𝐩 & 𝐒𝐜𝐚𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲: Cell sorting technologies need to be scalable and automated, allowing for the efficient production of large quantities of therapeutic cells. By automating the sorting process, we achieve consistent and reproducible results at scale, facilitating widespread adoption of cell and gene therapies.Cell sorting is a critical component of cell and gene therapy manufacture, enabling the precise isolation, characterization, and manipulation of therapeutic cells. By ensuring purity, quality, and scalability, we contribute to the development and commercialization of safe and effective cell-based therapies for a wide range of diseases and conditions.